The LDN 2021 Conference

Watch and learn from LDN experts.

Recordings from Friday 4th June – Sunday 6th 2021

The 2021 Conference Brochure - Click Here


The 2021 LDN AIIC Conference had discussions on the following disorders/topics: cancer, thyroid disorders, pain, erectile dysfunction, brain inflammation, psoriasis, depression, atopic dermatitis, Mast Cell Activation Syndrome (MCAS), Restless Leg Syndrome (RLS), mold toxicity, Small Intestinal Bacterial Overgrowth (SIBO), Multiple Sclerosis, rheumatology, lichen planopilaris, obesity, Henoch-Schonlein Purpura, PTSD and other mental health issues, Lyme Disease, fibromyalgia, skull reconstruction, Crohn’s disease, ulcerative colitis, special-needs children’s health, sarcoidosis, Mixed Connective Tissue Disease, eosinophilic esophagitis, lupus, infertility, autoimmunity, access protocols, ophthalmic conditions, longevity, EMF toxicity, and The LDN Side Effect Survey Results from 2020

Speakers and Presentations

  • Click the links below for the videos

LDN Research Trust 2021 Conference - Friday

     The role of immune modulation in cancer - Professor Angus Dalgleish

     Pain - Samyadev Datta, MD 

     History, Pharmacology and Mechanism - Stephen Dickson, BSC (hons) MRPharmS

     Hypothyroidism Variants - Elizabeth Livengood, NMD

     Early Biomarkers of a Brain on Fire - Tom O’Bryan, DC, CCN, DACBN

     Erectile Dysfunction Therapies - Yusuf, Saleeby, MD

     Psoriasis - Pamela Smith, MD, MS

LDN Research Trust 2021 Conference - Saturday

     How to treat pathologic cell behaviors - Mark Cooper, PhD

     Case Reports of Cancer Therapies - Akbar Khan, MD

     Drug Resistant Depression - Elizabeth Livengood, NMD

     Atopic Dermatitis - Pamela Smith, MD, MS

     Mast Cell Activation Syndrome (MCAS) - Leonard Weinstock, MD

     Restless Leg Syndrome - Leonard Weinstock, MD

     Mold toxicity - Leonard Weinstock, MD

     Nuts and Bolts of The Thyroid Gland: Therapeutic Targets - Sarah Zielsdorf, MD

LDN Research Trust 2021 Conference - Sunday

     Opiate Receptor Drugs – To Cycle or Not to Cycle Dosing? - Paul Anderson, NMD

     Cancer: Treatment Options - Andrew McCall, MD

     SIBO - Leonard Weinstock, MD

     Infection - Stefanie Werner, NMD

     Microbiome Medicine: Clinical Correlations From The Trenches - Sarah Zielsdorf, MD, MS

LDN Research Trust 2021 Conference - Extra Presentations

     Multiple Sclerosis - The role of combination therapy of LDN and Testosterone  ... - Harpal Bains, MD

     Rheumatology - Update 2021 - Edyta Biernat-Kaluza, MD, PhD

     Addressing the inflammatory impact of psoriasis - Apple Bodemer, MD

     Cooling the fire of lichen planopilaris - Apple Bodemer, MD

     Strategies for reducing excess body fat ... - Jill Brook, MA

     Henoch-Schonlein Purpura - Sally Daughtrey, ND

     PTSD and other mental health treatment with opioid antagonist ... - Gayln Forester, MS, LPC

     Lyme Disease - Darin Ingels, ND

     Cancer Case Studies - Akbar Khan, MD

     New approaches to managing fibromyalgia pain - Ginevra Liptan, MD 

     A Curious Case Study: When the only solution is Skull-Reconstruction - Elizabeth Livengood, NMD

     Endogenous opioids modulate inflammation in the animal model of Multiple Sclerosis - Chirag Patel, MD

     Delivery Systems - Yusuf Saleeby, MD

     Crohn’s - Pamela Smith, MD, MS

     Ulcerative Colitis - Pamela Smith, MD, MS

     Treating Children’s Health in a Special Needs Pediatric Practice - Brian Udell, MD 

     An Integrative Approach to Sarcoidosis and Mixed Connective Tissue Disease - Deanna Windham, DO

     Eosinophilic Esophagitis Is More Treatable Than You Think - Deanna Windham, DO

     Reclaim the Lives of Lupus Patients, A Unique Treatment Approach - Deanna Windham, DO

     A Non-Invasive First Approach Toward Idiopathic Female Infertility - Sarah Zielsdorf, MD, MS

     Autoimmunity in Families - Sarah Zielsdorf, MD, MS

LDN Research Trust 2021 Conference - Bonus Presentations

     Developing outcome centric, territory-specific access protocols for the provision of niche product  - John Bardsley

     The LDN Side Effect Survey Results from 2020 - Jill Brook, MA

     The Use of LDN for Ophthalmic Conditions - Sebastian Denison, Pharm

     Autoimmune thyroiditis Part 1 - Kent Holtorf, MD

     Autoimmune thyroiditis Part 2 - Kent Holtorf, MD

     Autoimmune thyroiditis Part 3 - Kent Holtorf, MD

     Longevity - Kent Holtorf, MD

     The EMF Toxicity Epidemic - Protection and Treatment - Kent Holtorf, MD

     Hypothyroidism - Dawn Ipsen, PharmD

     Use of LDN for Chronic Pain - Sahar Swidan, PHARM.D., ABAAHP, FAARFM, FACA